New PET scan may better predict chemo success in breast cancer

NCT ID NCT07553741

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a newer type of PET scan (68Ga-FAPI) can better predict if breast cancer has been fully eliminated by chemotherapy compared to standard PET scans (18F-FDG) and MRI. Twenty-seven women with breast cancer had all three scans before and after chemotherapy, then surgery to check results. The goal is to see which scan most accurately identifies complete response, potentially guiding future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
68Ga-FAPI-04 and 18F-FDG (imaging agents)
What this could lead to
If successful, this could show that a newer PET scan (FAPI) is more accurate than standard scans at predicting whether breast cancer has been eliminated by chemotherapy, helping doctors make better treatment decisions.
What could go wrong
This is a small, early study with only 27 participants, so results may not apply to all breast cancer patients. The imaging agents are for diagnosis only and do not treat the cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • China, Hubei Province

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.